Angiotensin AT1 receptor over-expression in hypercholesterolaemia

Annals of Medicine

Volumn 32, Issue 6, 2000, Pages 386-389

  Strehlow, K ^a   Wassmann, S ^a   Bohm, M ^a   Nickenig, G ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

AT1 receptor; Atherosclerosis; Hypercholesterolaemia; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL MODEL; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 0033795298     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853890008995944     Document Type: Review

References (27)

1. Renin-angiotensin system: Biochemistry and mechanism of action
2. Molecular biology of the renin-angiotensin system
3. Angiotensin II receptors and angiotensin II receptor antagonists
4. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The scandinavian simvastatin survival study (4S)
5. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of scotland coronary prevention study group
6. A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham study
7. Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit
8. Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia
9. Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression
10. Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and postranscriptional mechanisms: Evidence for homologuos and heterologous regulation
11. Estrogen modulates AT1 receptor gene expression in vitro and in vivo
12. Insulin induces up-regulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms
13. Salt induces vascular AT1 receptor overexpression in vitro and in vivo
14. The pathogenesis of atherosclerosis. A perspective for the 1990s
15. Up-regulation of vascular angiotensin II receptor gene expression by low density lipoprotein in vascular smooth muscle cells
16. Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression
17. Increased NADH-oxidase mediated superoxide production in the early stages of atherosclerosis: Evidence for involvement of the renin-angiotensin system
18. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men
19. Effect of Captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial
20. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction
21. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) study
22. Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction
23. The potential use of angiotensin-converting enzyme inhibitors in patients with hyperlipidemia
24. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
25. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured smooth muscle cells
26. Endothelial function and oxidant stress
27. Hypercholesterolemia increases endothelial superoxide anion production